OMB Home White House Website

Agency:    Department of Defense--Military
Bureau:    Research, Development, Test, and Evaluation
Account:    Research, development, test, and evaluation, Defense-wide (97-0400)
Certifying Official:    Deputy Comptroller Program/Budget
Contact Information:    http://WWW.DOD.GOV   703-697-5131
Oral Anthrax/Plaguevaccine

1 recipient will receive $2,800,000.
Year Enacted: 2005
Description: Develops new, safe and effective orally administered vaccines against anthrax and plague or any other microbes used as bioweapons. Avant is working through the DynPort Vaccine Company, LLC and DoD Joint Vaccine Acquisition Program.
Beneficiary/Recipient Amount ($K) Program Type Address
Avant Immunotherapeutics, Inc $2,800 For-Profit
Needham, MA
Source: Appropriations Report Language - Conference
Reference: 108-622
Location: Line 33, Page 345
Citation Excerpt: Oral Anthrax/Plaguevaccine

Last Modified: 16-Apr-2007

Federal Register    |   Jobs at OMB   |   FOIA   |  OMB Locator   |   |   Accessibility   |   Privacy Policy   |   Site Search   |   Help